Search research articles
Contact Us
Filters
Showing results (61-70 of 103) with videos related to
Page
of 11
Sort By:
International Journal of Hematology
|
January 26, 2011
A novel insertion mutation of K294RGG within BCR-ABL kinase domain confers imatinib resistance: sequential analysis of the clonal evolution in a patient with chronic myeloid leukemia in blast crisis
Katsuya Sakai, Yuichi Ishikawa, Yumiko Mori, et al.
Internal Medicine (Tokyo, Japan)
|
August 18, 2015
Rhabdomyolysis Caused by Candida parapsilosis in a Patient with Acute Myeloid Leukemia after Bone Marrow Transplantation
Seiji Kakiuchi, Kimikazu Yakushijin, Katsuya Yamamoto, et al.
Leukemia Research
|
March 25, 2026
Bi-directional association between RUNX1::RUNX1T1 and KIT mutations in acute myeloid leukemia: A multicenter genomic profiling study
Yuya Arai, Seiichiro Katagiri, SungGi Chi, et al.
Leukemia
|
April 17, 2023
Health-related quality of life of patients with resistant/intolerant chronic phase chronic myeloid leukemia treated with asciminib or bosutinib in the phase 3 ASCEMBL trial
Delphine Réa, Carla Boquimpani, Michael J Mauro, et al.
Blood Advances
|
September 2, 2020
The critical role of CD4+ T cells in PD-1 blockade against MHC-II-expressing tumors such as classic Hodgkin lymphoma
Joji Nagasaki, Yosuke Togashi, Takeaki Sugawara, et al.
European Journal of Haematology
|
December 17, 2009
BCR-ABL-independent and RAS / MAPK pathway-dependent form of imatinib resistance in Ph-positive acute lymphoblastic leukemia cell line with activation of EphB4
Momoko Suzuki, Akihiro Abe, Shizuka Imagama, et al.
Clinical and Experimental Pharmacology & Physiology
|
June 23, 2016
Iron-chelating agent, deferasirox, inhibits neutrophil activation and extracellular trap formation
Mari Kono, Katsuyasu Saigo, Shiori Yamamoto, et al.
International Journal of Hematology
|
November 29, 2008
Retention but significant reduction of BCR-ABL transcript in hematopoietic stem cells in chronic myelogenous leukemia after imatinib therapy
Akihiro Abe, Yosuke Minami, Fumihiko Hayakawa, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
February 8, 2021
[Disseminated aspergillosis due to Aspergillus udagawae during immunosuppressive treatment for myelodysplastic syndrome]
Ayumi Kuzume, Junichiro Yuda, Masahiro Abe, et al.
Biochimica Et Biophysica Acta
|
February 18, 2014
Phosphorylated Sp1 is the regulator of DNA-PKcs and DNA ligase IV transcription of daunorubicin-resistant leukemia cell lines
Yayoi Nishida, Naoki Mizutani, Minami Inoue, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 103) with videos related to
Sort By:
Page
of 11
International Journal of Hematology
|
January 26, 2011
A novel insertion mutation of K294RGG within BCR-ABL kinase domain confers imatinib resistance: sequential analysis of the clonal evolution in a patient with chronic myeloid leukemia in blast crisis
Katsuya Sakai, Yuichi Ishikawa, Yumiko Mori, et al.
Internal Medicine (Tokyo, Japan)
|
August 18, 2015
Rhabdomyolysis Caused by Candida parapsilosis in a Patient with Acute Myeloid Leukemia after Bone Marrow Transplantation
Seiji Kakiuchi, Kimikazu Yakushijin, Katsuya Yamamoto, et al.
Leukemia Research
|
March 25, 2026
Bi-directional association between RUNX1::RUNX1T1 and KIT mutations in acute myeloid leukemia: A multicenter genomic profiling study
Yuya Arai, Seiichiro Katagiri, SungGi Chi, et al.
Leukemia
|
April 17, 2023
Health-related quality of life of patients with resistant/intolerant chronic phase chronic myeloid leukemia treated with asciminib or bosutinib in the phase 3 ASCEMBL trial
Delphine Réa, Carla Boquimpani, Michael J Mauro, et al.
Blood Advances
|
September 2, 2020
The critical role of CD4+ T cells in PD-1 blockade against MHC-II-expressing tumors such as classic Hodgkin lymphoma
Joji Nagasaki, Yosuke Togashi, Takeaki Sugawara, et al.
European Journal of Haematology
|
December 17, 2009
BCR-ABL-independent and RAS / MAPK pathway-dependent form of imatinib resistance in Ph-positive acute lymphoblastic leukemia cell line with activation of EphB4
Momoko Suzuki, Akihiro Abe, Shizuka Imagama, et al.
Clinical and Experimental Pharmacology & Physiology
|
June 23, 2016
Iron-chelating agent, deferasirox, inhibits neutrophil activation and extracellular trap formation
Mari Kono, Katsuyasu Saigo, Shiori Yamamoto, et al.
International Journal of Hematology
|
November 29, 2008
Retention but significant reduction of BCR-ABL transcript in hematopoietic stem cells in chronic myelogenous leukemia after imatinib therapy
Akihiro Abe, Yosuke Minami, Fumihiko Hayakawa, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
February 8, 2021
[Disseminated aspergillosis due to Aspergillus udagawae during immunosuppressive treatment for myelodysplastic syndrome]
Ayumi Kuzume, Junichiro Yuda, Masahiro Abe, et al.
Biochimica Et Biophysica Acta
|
February 18, 2014
Phosphorylated Sp1 is the regulator of DNA-PKcs and DNA ligase IV transcription of daunorubicin-resistant leukemia cell lines
Yayoi Nishida, Naoki Mizutani, Minami Inoue, et al.
Page
of 11